DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

被引:1907
作者
Geijtenbeek, TBH
Kwon, DS
Torensma, R
van Vliet, SJ
van Duijnhoven, GCF
Middel, J
Cornelissen, ILMHA
Nottet, HSLM
KewalRamani, VN
Littman, DR
Figdor, CG
van Kooyk, Y
机构
[1] Univ Med Ctr St Radboud, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands
[2] Univ Med Ctr St Radboud, Dept Pathol, NL-6525 EX Nijmegen, Netherlands
[3] Univ Utrecht Hosp, Eykman Winkler Inst Microbiol, NL-3584 CX Utrecht, Netherlands
[4] NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA
[5] NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA
关键词
D O I
10.1016/S0092-8674(00)80694-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DC) capture microorganisms that enter peripheral mucosal tissues and then migrate to secondary lymphoid organs, where they present these in antigenic form to resting T cells and thus initiate adaptive immune responses. Here, we describe the properties of a DC-specific C-type lectin, DC-SIGN, that is highly expressed on DC present in mucosal tissues and binds to the HIV-1 envelope glycoprotein gp120. DC-SIGN does not function as a receptor for viral entry into DC but instead promotes efficient infection in trans of cells that express CD4 and chemokine receptors. We propose that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.
引用
收藏
页码:587 / 597
页数:11
相关论文
共 37 条
  • [1] A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells
    Adema, GJ
    Hartgers, F
    Verstraten, R
    deVries, E
    Marland, G
    Menon, S
    Foster, J
    Xu, YM
    Nooyen, P
    McClanahan, T
    Bacon, KB
    Figdor, CG
    [J]. NATURE, 1997, 387 (6634) : 713 - 717
  • [2] Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
    Ayehunie, S
    GarciaZepeda, EA
    Hoxie, JA
    Horuk, R
    Kupper, TS
    Luster, AD
    Ruprecht, RM
    [J]. BLOOD, 1997, 90 (04) : 1379 - 1386
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] BarrattBoyes SM, 1997, J IMMUNOL, V158, P4543
  • [5] Bjorndal A, 1997, J VIROL, V71, P7478
  • [6] Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways
    Blauvelt, A
    Asada, H
    Saville, MW
    KlausKovtun, V
    Altman, DJ
    Yarchoan, R
    Katz, SI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 2043 - 2053
  • [7] Dendritic cells and the replication of HIV-1
    Cameron, P
    Pope, M
    GranelliPiperno, A
    Steinman, RM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (02) : 158 - 171
  • [8] SUSCEPTIBILITY OF DENDRITIC CELLS TO HIV-1 INFECTION IN-VITRO
    CAMERON, PU
    LOWE, MG
    CROWE, SM
    ODOHERTY, U
    POPE, M
    GEZELTER, S
    STEINMAN, RM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (03) : 257 - 265
  • [9] DENDRITIC CELLS EXPOSED TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMIT A VIGOROUS CYTOPATHIC INFECTION TO CD4+ T-CELLS
    CAMERON, PU
    FREUDENTHAL, PS
    BARKER, JM
    GEZELTER, S
    INABA, K
    STEINMAN, RM
    [J]. SCIENCE, 1992, 257 (5068) : 383 - 386
  • [10] The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34+ hematopoietic progenitor cells is primarily determined by their maturation stage
    Canque, B
    Bakri, Y
    Camus, S
    Yagello, M
    Benjouad, A
    Gluckman, JC
    [J]. BLOOD, 1999, 93 (11) : 3866 - 3875